Qing Tian Selected Research

calyculin A

11/2007	Dehydroevodiamine attenuates calyculin A-induced tau hyperphosphorylation in rat brain slices.
8/2007	Inhibition of protein phosphatases induces transport deficits and axonopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qing Tian Research Topics

Disease

33	Alzheimer Disease (Alzheimer's Disease) 03/2021 - 09/2002
21	Osteoporosis 01/2021 - 01/2011
18	Neoplasms (Cancer) 11/2021 - 10/2003
11	Memory Disorders (Memory Loss) 01/2020 - 08/2007
10	Obesity 01/2022 - 01/2011
9	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2021 - 05/2008
8	Cognitive Dysfunction 01/2022 - 08/2011
8	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 05/2010
8	Type 2 Diabetes Mellitus (MODY) 05/2021 - 10/2014
6	Dementia (Dementias) 01/2021 - 11/2007
6	Inflammation (Inflammations) 01/2021 - 07/2013
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2010
5	Schizophrenia (Dementia Praecox) 01/2022 - 11/2013
5	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2003
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2016
4	Stroke (Strokes) 06/2021 - 10/2014
4	Hypoxia (Hypoxemia) 01/2020 - 09/2005
4	Hyperhomocysteinemia 01/2019 - 04/2009
4	Pancreatic Neoplasms (Pancreatic Cancer) 11/2018 - 06/2014
3	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2020
3	Wounds and Injuries (Trauma) 11/2021 - 01/2020
3	Pathologic Processes 03/2021 - 12/2004
3	Infections 01/2021 - 05/2010
3	Ovarian Neoplasms (Ovarian Cancer) 11/2020 - 03/2009
3	Hypoglycemia (Reactive Hypoglycemia) 10/2020 - 04/2016
3	Diabetes Mellitus 10/2020 - 12/2005
3	Necrosis 01/2020 - 09/2013
3	Tauopathies 01/2020 - 02/2007
3	Carcinoma (Carcinomatosis) 02/2018 - 02/2011
3	Lung Neoplasms (Lung Cancer) 12/2012 - 10/2003
2	COVID-19 01/2022 - 11/2020
2	Osteosarcoma (Osteogenic Sarcoma) 12/2021 - 01/2013
2	Carcinogenesis 11/2021 - 04/2007
2	Cerebral Hemorrhage 09/2021 - 10/2020
2	Body Weight (Weight, Body) 05/2021 - 10/2020
2	Disease Progression 05/2021 - 01/2010
2	Sepsis (Septicemia) 01/2021 - 04/2013
2	Cicatrix (Scar) 01/2020 - 05/2017
2	Hypothermia 01/2020 - 10/2017
2	Edema (Dropsy) 03/2019 - 11/2015

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2005
15	Biological ProductsIBA 01/2021 - 04/2007
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2011
9	Amyloid (Amyloid Fibrils)IBA 01/2021 - 08/2006
7	Phosphotransferases (Kinase)IBA 01/2020 - 06/2008
6	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 10/2017
6	MelatoninIBA 01/2021 - 08/2007
6	Peptides (Polypeptides)IBA 01/2020 - 12/2004
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2016
5	IronIBA 01/2021 - 08/2011
5	Glycogen Synthase (Synthase I)IBA 01/2020 - 11/2007
5	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 07/2013 - 09/2005
5	Amyloid beta-PeptidesIBA 04/2009 - 12/2004
4	Long Noncoding RNAIBA 11/2021 - 01/2019
4	Metformin (Glucophage)FDA LinkGeneric 05/2021 - 01/2017
4	Therapeutic UsesIBA 01/2021 - 10/2014
4	Pharmaceutical PreparationsIBA 01/2021 - 07/2015
4	MicroRNAs (MicroRNA)IBA 01/2020 - 11/2012
4	ChromatinIBA 02/2019 - 11/2015
4	Cholinergic Agents (Cholinergics)IBA 12/2017 - 07/2013
4	ErbB Receptors (EGF Receptor)IBA 06/2013 - 01/2010
4	Tyrosine Kinase InhibitorsIBA 06/2013 - 01/2010
4	Immunoglobulin G (IgG)IBA 06/2005 - 03/2004
3	LipidsIBA 01/2022 - 01/2013
3	HydrogenIBA 01/2022 - 07/2015
3	Exenatide (Byetta)FDA Link 05/2021 - 03/2019
3	Mitochondrial Permeability Transition PoreIBA 01/2021 - 01/2020
3	Messenger RNA (mRNA)IBA 01/2021 - 06/2018
3	MineralsIBA 01/2021 - 12/2018
3	Mitochondrial DNA (mtDNA)IBA 01/2021 - 01/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2020
3	PlatinumIBA 11/2020 - 01/2020
3	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 07/2015
3	Insulin (Novolin)FDA Link 10/2020 - 10/2014
3	Oxygen (Dioxygen)IBA 01/2020 - 03/2004
3	tau Proteins (tau Protein)IBA 01/2020 - 10/2009
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2019 - 10/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2014
3	AcidsIBA 02/2016 - 03/2013
3	Heme (Haem)IBA 03/2013 - 06/2008
3	Gefitinib (Iressa)FDA Link 09/2011 - 01/2010
3	Glycogen Synthase Kinase 3IBA 09/2008 - 09/2005
3	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 11/2007 - 09/2002
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2022 - 01/2020
2	Glutamic Acid (Glutamate)FDA Link 01/2022 - 07/2015
2	LeptinIBA 01/2022 - 01/2020
2	Insulin SecretagoguesIBA 05/2021 - 08/2020
2	fibroblast growth factor 21IBA 05/2021 - 03/2019
2	AlkaloidsIBA 03/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 12/2019
2	Emodin (Archin)IBA 01/2021 - 01/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2020 - 01/2020
2	CurcuminIBA 11/2020 - 11/2020
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 08/2007
2	EndotoxinsIBA 01/2020 - 09/2011
2	HomocysteineIBA 01/2019 - 01/2011
2	Transcription Factors (Transcription Factor)IBA 12/2018 - 01/2016

Therapy/Procedure

17	Therapeutics 11/2021 - 10/2003
3	Drug Therapy (Chemotherapy) 11/2020 - 07/2015
2	Length of Stay 10/2021 - 11/2015